There was no difference in the prevalence of anaemia between the simeprevir and placebo groups ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- , respectively , at @ weeks , and @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- , respectively , during the entire treatment ) .